Development of clinical hyperspectral imaging system for head and neck tumors

ORAL

Abstract


Early-stage cancer detection and classification significantly increase the chances of successful treatment. In this study, we aim to develop a portable clinical hyperspectral imaging (HSI) system for the detection and classification of skin tumors in the head and neck region.



The tripod mounted system is based on a handheld hyperspectral camera (IQ, Specim, Finland) with an additional achromatic doublet lens to achieve sub-millimeter spatial resolution. The imaging regions were illuminated with a halogen lamp coupled to a ring illuminator providing bright and homogenous illumination. Tissue topography was also captured using two time-of-flight cameras (flexx2, PMD, Germany).



Three types of tumors were imaged in the study: benign papillary nevi, and malignant basal and squamous cell carcinomas. Hyperspectral images were analyzed using tissue indices, a metric that estimates various tissue properties, including melanin content, blood content, and oxygenation. Preliminary results show significant differences between tissues: malignant tumors have less melanin than benign ones (p<0.05) and tumors differ from healthy tissue in oxygenation (p<0.02).



Results show that a portable clinical HSI system could assist in early tumor detection, leading to better treatment outcome.

*This work was supported by Slovenian Research and Innovation Agency (ARIS) grants P1-0389, P3-0003, Z1-4384, J3-2529, and J3-3083.

Presenters

  • Črt Keber

    • University of Ljubljana, Faculty of Mathematics and Physics

Authors

  • Črt Keber

    • University of Ljubljana, Faculty of Mathematics and Physics
  • Aljosa Krt

    • General hospital Izola
  • Crt Jamsek

    • Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana
  • Tadej Tomanic

    • University of Ljubljana
  • Jost Stergar

    • J. Stefan Institute
    • Jožef Stefan Institute
  • Tim Bozic

    • Department of Experimental Oncology, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia
    • Institute of Oncology Ljubljana
  • Bostjan Markelc

    • Department of Experimental Oncology, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia
    • Institute of Oncology Ljubljana
  • Ales Groselj

    • Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana
  • Gregor Sersa

    • Department of Experimental Oncology, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia
    • Institute of Oncology Ljubljana
  • Matija Milanic

    • University of Ljubljana